Clinical Trials Sponsored by Pivotal Therapeutics
Total 6291 results
-
NovelMed TherapeuticsNot yet recruitingPNH - Paroxysmal Nocturnal Hemoglobinuria
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria
-
Westlake TherapeuticsRecruitingCancer | Solid Tumor | Hematologic MalignancyChina
-
Intellia TherapeuticsRecruitingTransthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac AmyloidosisUnited Kingdom, New Zealand, Sweden
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
Sage TherapeuticsRecruitingHuntington DiseaseUnited States, Canada
-
NovelMed TherapeuticsNot yet recruitingC3 Glomerulopathy
-
NovelMed TherapeuticsNot yet recruitingParoxysmal Nocturnal Hemoglobinuria
-
Chimeric TherapeuticsRecruitingGlioblastoma Multiforme of BrainUnited States
-
Dragonfly TherapeuticsRecruiting
-
Stemirna TherapeuticsRecruitingEfficacy | Safety | ImmunogenicityLao People's Democratic Republic
-
Verismo TherapeuticsRecruitingOvarian Cancer | Mesothelioma, Malignant | Cholangiocarcinoma RecurrentUnited States
-
APRINOIA TherapeuticsRecruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseChina
-
Dyne TherapeuticsRecruitingDuchenne Muscular Dystrophy (DMD)United States, Belgium, Canada, United Kingdom, Australia, Spain, Italy
-
Omega TherapeuticsRecruitingHepatocellular Carcinoma | Solid Tumor | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Recurrent | Liver, Cancer of, Non-ResectableUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States
-
MitoImmune TherapeuticsRecruitingLymphoma | Multiple Myeloma | Oral Mucositis | Hematologic CancerKorea, Republic of
-
Allergy TherapeuticsRecruitingPeanut AllergyUnited States
-
AUG TherapeuticsRecruitingLeukocyte Adhesion DeficiencyUnited States
-
Plus TherapeuticsNot yet recruiting
-
Lexeo TherapeuticsRecruitingAlzheimer DiseaseUnited States
-
Freeline TherapeuticsRecruitingGaucher Disease, Type 1Spain, Israel, United States, United Kingdom, Brazil, Germany, Paraguay
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia
-
IntraGel TherapeuticsNot yet recruiting
-
Fate TherapeuticsRecruiting
-
Fulcrum TherapeuticsRecruitingSickle Cell Disease | Sickle Cell AnemiaUnited States
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
Karuna TherapeuticsRecruitingSchizophreniaUnited States, Bulgaria, Serbia
-
Visus TherapeuticsRecruiting
-
Tenaya TherapeuticsRecruitingNatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy (MyCLIMB)CardiomyopathyUnited States, Canada, United Kingdom, Spain
-
Sage TherapeuticsRecruitingHuntington's DiseaseUnited States, Australia, Canada, United Kingdom
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Faeth TherapeuticsRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic AdenocarcinomaUnited States
-
Aerovate TherapeuticsRecruitingPulmonary Arterial HypertensionUnited States, Belgium, Italy, Spain, Australia, Canada, China, Poland, Singapore, Argentina, United Kingdom, France, Israel, Latvia, Austria, Mexico, Puerto Rico, Sweden, South Africa, Netherlands, Chile, Germany, Greece, Portugal, Cze... and more
-
Allogene TherapeuticsRecruitingAdvanced/Metastatic Clear Cell Renal Cell CarcinomaUnited States
-
LIDDE TherapeuticsRecruitingHemorrhagic CystitisFrance
-
Harpoon TherapeuticsRecruitingSmall-cell Lung CancerUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
Corcept TherapeuticsRecruitingHypercortisolismUnited States, Austria, Bulgaria, Germany, Israel, Italy, Poland, Romania, Spain
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
BioEclipse TherapeuticsRecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Osteosarcoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumor, Adult | Malignant MelanomaUnited States
-
Amicus TherapeuticsRecruiting
-
Aspa TherapeuticsRecruiting
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Taiwan, Japan, Australia, Canada
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom